Nouscom

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• Infinitopes infinitopes.comDirect competitorBoth develop off-the-shelf viral-vector cancer vaccines to induce strong anti-tumor T-cell responses.
• VLP Therapeutics vlptherapeutics.comDirect competitorBoth design therapeutic cancer vaccines using virus-based platforms to treat tumors.
• Epitopea epitopea.comPartial overlapBoth create off-the-shelf cancer vaccines targeting shared tumor antigens to drive anti-tumor immunity.
• Oncorus oncorus.comPartial overlapBoth use viral and RNA platforms to develop systemic cancer immunotherapies.
• Omios Bio omiosbio.comPartial overlapBoth engineer viral platforms for cancer immunotherapy including oncolytic virus approaches.
• Candel Therapeutics candeltx.comPartial overlapBoth develop viral immunotherapies that expose tumor neoantigens and stimulate anti-tumor immune responses.
• Genelux Corporation genelux.comPartial overlapBoth use vaccinia-based viral platforms for oncolytic immunotherapies against solid tumors.
• Enterome enterome.comPartial overlapBoth develop off-the-shelf cancer immunotherapies that elicit durable anti-tumor T-cell responses.